Virtus Investment Advisers, Inc. Bristol Myers Squibb CO Transaction History

Virtus Investment Advisers, Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $279 - $165,052	2,148 New	2,148 $153,000
Q1 2018 May 15, 2018	SELL	$59.92 - $68.98 $412,249 - $474,582	-6,880 Closed	0 $0
Q4 2017 Feb 26, 2018	SELL	$59.94 - $65.35 $1.62 Million - $1.76 Million	-26,993 Reduced 79.69%	6,880 $422,000
Q4 2017 Feb 14, 2018	BUY	$59.94 - $65.35 $2.03 Million - $2.21 Million	33,873	33,873 $424,000

2,536

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $126B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Virtus Investment Advisers, Inc., based on Form 13F filings with the SEC.

Stay updated on Virtus Investment Advisers, Inc. with notifications on news.